CBUS CIBUS INC

Cibus CEO to Highlight Gene Editing’s Role in Building Resilient Agriculture at UN Climate Week 2025

Cibus CEO to Highlight Gene Editing’s Role in Building Resilient Agriculture at UN Climate Week 2025

SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will participate in a featured panel during UN Climate Week 2025 in New York City.

The event, titled “Investing in a Resilient Future: Innovation, Data & Capital for Energy, Food, Water, and Climate Solutions”, supported by Syntax Data, will be held on Tuesday, September 23rd at Midtown Loft, New York City, with a livestream available .

Dr. Beetham will join leaders from the United Nations Development Programme (UNDP), the World Bank, and Syntax Data for a discussion on “Biotech Meet Bytes: Innovation and Policy Pathways for Resilient Futures.” The session will explore how biotechnology, artificial intelligence, and other emerging technologies can strengthen resilience in food, water, and energy systems while aligning with the UN Sustainable Development Goals (SDGs).

“Food and agriculture are at the heart of building resilient societies,” said Dr. Beetham. “At Cibus, we believe gene editing can deliver crops that are more productive, more sustainable, and more adaptable to changing climate conditions. I’m honored to join this distinguished group of global leaders to discuss how innovation, policy, and investment can come together to advance resilient solutions for people and the planet.”

The session is scheduled for 3:35pm ET on Tuesday, September 23rd and will be moderated by Omino Gardezi of Syntax. Other panelists include Laurel Patterson, Director of Strategic Partnerships & Communications at UNDP, and Arianna Legovini, Founding Director of Development Impact at the World Bank.

For more information please visit, .

About Cibus

Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus’ long-term focus is productivity traits for farmers for the major global row crops. Cibus is not a seed company. It is a technology company that uses proprietary high-throughput gene editing technology to develop at a fraction of the time and cost of conventional breeding and to license them to seed companies in exchange for royalties on seed sales. For more information, please visit .

Cibus Contacts:

INVESTOR RELATIONS

Jeff Sonnek – ICR

MEDIA RELATIONS

Colin Sanford – Bioscribe



EN
22/09/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CIBUS INC

 PRESS RELEASE

Cibus Partnering with The John Innes Centre for UK Government’s Farmin...

Cibus Partnering with The John Innes Centre for UK Government’s Farming Innovation Programme Precision Breeding Initiative Cibus to utilize proprietary Rapid Trait Development System™ to enable development of durable resistance to Light Leaf Spot disease, which has caused estimated yield losses of up to £300m in recent years SAN DIEGO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its participation as a key technology partner in...

 PRESS RELEASE

Cibus, Inc. Announces Pricing of $20.0 Million Public Offering of Clas...

Cibus, Inc. Announces Pricing of $20.0 Million Public Offering of Class A Common Stock SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the pricing of an underwritten public offering of 13,333,333 shares of its Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), at a public offering price of $1.50 per share (the “Offering”). Members of Cibus’ Board of Directors will purchase 1,000,000 shares of Class...

 PRESS RELEASE

Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock

Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock SAN DIEGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that it intends to offer shares of its Class A common stock, par value $0.0001 per share (“Class A Common Stock”), in an underwritten public offering (the “Offering”). Cibus also expects to grant to the underwriter of the Offering a 30-day option to purchase up to an additional 15% of the shares of Class A...

 PRESS RELEASE

Cibus and Interoc Advance Rice Commercialization Strategy for Herbicid...

Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America Nonbinding Letter of Intent (LOI) sets framework for potential 2027 market entry in Ecuador and Colombia, followed by expansion into Peru, Central America and the Caribbean Expected to build on success under the existing 2024 material transfer agreement, shifting focus to market execution and revenue generation for co-developed herbicide-tolerant (HT) rice traits SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technol...

 PRESS RELEASE

Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New...

Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council Political agreement on New Genomic Techniques (NGTs), including gene editing, advances a science-based path for plant breeding innovation and supports Cibus’ plans to bring improved traits to European growers The agreed legislative text outlining a framework for NGTs in the EU will now move to formal endorsement by the European Parliament and Council SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a lea...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch